Infraredx Agreement with HealthTrust to Offer Intravascular Imaging Technology

Infraredx, Inc. (Burlington, MA, USA), a medical device company focused on the diagnosis and management of coronary artery disease, has entered into an agreement with HealthTrust (San Jose, CA, USA), a US group purchasing organization. Under the agreement, HealthTrust will offer the Infraredx TVC imaging system, an innovative dual-modality intravascular imaging technology, to its member network of 1,400 acute care facilities in the United States.

The TVC imaging system is used to guide percutaneous coronary interventions (PCIs) by integrating near-infrared spectroscopy (NIRS) to detect lipid-core plaques and intravascular ultrasound (IVUS) to visualize the vessel, including the structure of plaques and the level of stenosis caused by plaque accumulation. Lipid-core plaque is a fatty coronary artery plaque known to cause PCI complications, and the rupture of lipid-core plaque is associated with most heart attacks.

“We are pleased to be selected by HealthTrust to provide our innovative TVC imaging system now to more than 25% of the hospital healthcare facilities across the United States,” said Don Southard, president and chief executive officer of Infraredx. “Our contract will enable HealthTrust members access to our novel dual-modality intravascular imaging technology, which provides valuable information for physicians to make procedural and patient care decisions aimed at improving clinical outcomes and lowering healthcare costs.”

Related Links:
Infraredx
HealthTrust